Skip to main content
Log in

Update zum Typ-1-Diabetes

Update on type 1 diabetes

  • Leitthema
  • Published:
Der Diabetologe Aims and scope

Zusammenfassung

Für die vorliegende Literaturübersicht wurden sämtliche Publikationen aus 2013, die sich mit Typ-1-Diabetes beschäftigten, durchgesehen und die 18 für die praktisch-klinische Diabetologie wichtigsten Beiträge ausgewählt. Im Folgenden werden der jeweilige Hintergrund der Arbeit, in übersichtlicher Form die Methoden und das Ergebnis sowie eine Würdigung mit einem Fazit für die Praxis dargestellt.

Abstract

This review extracted the 18 most important publications dealing with diabetes mellitus type 1 from the literature published in 2013. The background of each publication is presented together with the methods and results. Implications for daily practice are provided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Bergenstal RM, Klonoff DC, Garg SK et al (2013) Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369:224–302

    Article  CAS  PubMed  Google Scholar 

  2. Buckingham D, Beck RW, Ruedy KJ et al (2013) Effectivness of early intensive therapy on β-Cell preservation in Type 1 Diabetes. Diabetes Care 36:4030–4035

    Article  CAS  PubMed  Google Scholar 

  3. Choudhary G, Ramasamy S, Green L et al (2013) Real-time continuous glucose monitoring significant reductions of hypoglycemia in hypoglycemia-unerware-patients with type 1 diabetes. Diabetes Care 36:4160–4162

    Article  CAS  PubMed  Google Scholar 

  4. Damiano IR, El-Khatib FH, Zheng H et al (2013) A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care 36:251–259

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Zeeuw D de, Akizawa T, Audhya P et al (2013) Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 369:2492–2503

    Article  PubMed  Google Scholar 

  6. Fredheim S, Johannesen J, Johansen A et al (2013) Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels. Diabetologia 56:995–1003

    Article  CAS  PubMed  Google Scholar 

  7. Hietala K, Wadén J, Forsblom C et al (2013) HbA1c-Variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes. Diabetologia 56:737–745

    Article  CAS  PubMed  Google Scholar 

  8. Jacobs-Tulleneers-Thevissen D, Chintinne M, Ling Z et al (2013) Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia 56:1605–1614

    Article  CAS  PubMed  Google Scholar 

  9. Jørgensen ME, Almdal TP, Carstensen B (2013) Time trends in mortality rates in type 1 diabetes from 2002 to 2011. Diabetologia 56:2401–2404

    Article  PubMed  Google Scholar 

  10. Le Caire TJ, Palta M, Klein R et al (2013) Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study (WDRS) and the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care 36:631–637

    Article  Google Scholar 

  11. Ly TT, Nicholas JA, Retterath A et al (2013) Effect of sensor-augmented insulinpump therapy and automated insulin suspension with the standard insulin pump therapy and hypoglycemia inpatient with type 1 diabetes. Randomized, controlled trials. JAMA 310:1240–1247

    Article  CAS  PubMed  Google Scholar 

  12. Mader JK, Birngruber T, Korsatko S et al (2013) Enhanced absorption of insulin as part as the result of a dispersed injection strategy tested in a randomized trial in type 1 diabetic patients. Diabetes Care 36:780–785

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Moran A, Bundy B, Becker DJ et al (2013) Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381:1905–1916

    Article  CAS  PubMed  Google Scholar 

  14. Phillip M, Battelino T, Atlas E et al (2013) Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 368:824–833

    Article  CAS  PubMed  Google Scholar 

  15. Schaefer MK, Kossover RA, Perz JF (2013) Sharing insulinpens: are you putting patients at risk? Diabetes Care 36:188–190

    Article  Google Scholar 

  16. Sherr JL, Palau Collazo M, Cengiz E et al (2014) Safety of night time 2 hours suspension of basal insulin in pump treatment type 1 diabetes even in the absence of low glucose. Diabetes Care 37:773–779

    Article  CAS  PubMed  Google Scholar 

  17. Wisting L, Frøisland DH, Skrivarhaug T et al (2013) Disturbed eating behavior and omission of insulin in adolescents receiving intensified insulin treatment: a nationwide population-based study. Diabetes Care 36:3382–3387

    Article  CAS  PubMed  Google Scholar 

  18. Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple autoalted autoantibodies and risk of progression to diabetes in children. JAMA 309:2473–2479

    Article  CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. M. Dreyer hat von den Firmen Novo, Lilly und MSD Vortragshonorare erhalten. Der Beitrag enthält keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Dreyer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dreyer, M. Update zum Typ-1-Diabetes. Diabetologe 10, 368–375 (2014). https://doi.org/10.1007/s11428-013-1193-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-013-1193-1

Schlüsselwörter

Keywords

Navigation